Archive by Tag: transparency

Biopharma Giant Tabs Thought Leader Select for Initiatives in Companion Diagnostics for Oncology Products

July 9, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader has chosen Thought Leader Select to perform critical research and advisory work in support of key opinion leader initiatives advancing companion diagnostics for oncology medications. Thought Leader Select, headquartered in Chapel[...]

International Pharma Chooses Thought Leader Select for Women’s Health Initiative with Key Opinion Leaders, Centers of Excellence

November 6, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in Canada focused on key opinion leaders and medical centers of[...]

The Sunshine Act: The Good, the Bad, and the Ugly

Industry Insights from Paul Meade, M. Sc, MPH The Sunshine Act is on the horizon, and all we know for certain is that things will be different. Will the changes be good, bad, or ugly for healthcare and the biopharmaceutical[...]

Paul Meade Accepts Invitation to Speak at AACE Annual Meeting

March 31, 2011 (CHAPEL HILL, NC)—Paul Meade, the president and founder of Thought Leader Select, a Research Triangle, NC company focused on facilitating medical expert collaborations with the biopharmaceutical and other healthcare industries, has accepted an invitation to speak at[...]

Transparency and the Sunshine Provision – Is This a Good or Bad Thing?

Industry Insights from Paul Meade, M.Sc., MPH The Physician Payment Sunshine Provision is a part of the Patient Protection and Affordable Care Act passed by the U. S. Congress in March of last year. The provision will go into effect[...]

How Will Healthcare Reform Impact Your Next Investigator or Advisory Board Meeting?

Regulatory Guidance from Aprel Buonpane The main components of the new US healthcare reform legislation will continue to be subjects for debate in the coming months and years, but tucked in among all of the changes for Medicare beneficiaries, coverage[...]

The Sunshine Act and Working with Thought Leaders

Industry Insights from Paul Meade, M.Sc. MPH With the Sunshine Act getting closer to implementation, every company that works with thought leaders is preparing for full disclosure and transparency in the way they work and compensate these physicians and other[...]

The Thought Leaders Driving Thought Leader Select–A Blog Series: Lisa Smith

Lisa Smith helped to start Thought Leader Select in 2006 with Paul Meade and Kristen Smithwick. As Executive Vice President of Research and Development, Lisa ensures the company’s highest research standards. She has years of experience leading research and consulting[...]

Throwing the Baby Out with the Bath Water: ACCME Bans Industry Scientists from CME

Industry Insights from Paul Meade, M. Sc, MPH A recent decision by the Accreditation Council for Continuing Medical Education to not allow scientists employed by pharmaceutical, diagnostics, and devices companies to give educational presentations to physicians at medical meetings has[...]

Fast Facts from Thought Leader Select–Payer KOLs

Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their[...]